Methotrexate and Lung Disease in Rheumatoid Arthritis: A Meta-Analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

Methotrexate and Lung Disease in Rheumatoid Arthritis: A Meta-Analysis of Randomized Controlled Trials

Published:2014-03-28 Issue:4 Volume:66 Page:803-812
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Conway Richard¹,Low Candice²,Coughlan Robert J.¹,O'Donnell Martin J.³,Carey John J.¹

Affiliation:

1. Galway University Hospitals, Merlin Park; Galway Ireland

2. St. James's Hospital; Dublin Ireland

3. National University of Ireland; Galway Ireland

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Reference64 articles.

1. The burden of musculoskeletal disease: global perspective;Brooks;Clin Rheumatol,2006

2. Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies;Meune;Rheumatology (Oxford),2009

3. All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database;Watson;J Rheumatol,2003

4. Mortality in rheumatoid arthritis: 2008 update;Sokka;Clin Exp Rheumatol,2008

5. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis;Saag;Arthritis Rheum,2008

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring rheumatoid arthritis associated interstitial lung disease a retrospective study from two Saudi tertiary care centers;BMC Rheumatology;2024-08-05

2. Use of methotrexate and TNF inhibitors in patients with rheumatoid arthritis–associated interstitial lung disease: a survey of rheumatologists;Clinical Rheumatology;2024-07-31

3. Prognostic factors for interstitial lung disease progression in rheumatoid arthritis: May methotrexate protect against progression?;Scandinavian Journal of Rheumatology;2024-07-25

4. Risk factors of incident lung diseases and the impact of DMARDs in rheumatoid arthritis patients: a longitudinal study;2024-07-23

5. Méthotrexate à faible dose : indications et effets secondaires, en particulier en cas de pneumopathie interstitielle diffuse;Revue des Maladies Respiratoires;2024-07